Published in EMBO J on August 10, 1998
Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol (2000) 8.62
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J (2004) 5.67
Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc Natl Acad Sci U S A (2002) 4.66
A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc Natl Acad Sci U S A (2004) 3.73
HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology (2008) 3.72
A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc Natl Acad Sci U S A (2004) 3.60
Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol (2009) 2.95
An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J Virol (1998) 2.73
HIV Restriction Factors and Mechanisms of Evasion. Cold Spring Harb Perspect Med (2012) 2.72
APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos Trans R Soc Lond B Biol Sci (2009) 2.40
Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. Clin Microbiol Rev (2006) 2.28
Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G. J Virol (2004) 2.27
Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA. J Virol (2001) 2.16
Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process. J Virol (2000) 2.11
Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol (2000) 2.04
Human immunodeficiency virus, restriction factors, and interferon. J Interferon Cytokine Res (2009) 1.94
Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol (2012) 1.94
Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J Virol (2005) 1.84
APOBEC3G targets specific virus species. J Virol (2004) 1.78
Mutational analysis of the human immunodeficiency virus type 1 Vif protein. J Virol (1999) 1.52
Novel approaches to inhibiting HIV-1 replication. Antiviral Res (2009) 1.48
Further investigation of simian immunodeficiency virus Vif function in human cells. J Virol (2004) 1.46
Vif and the p55(Gag) polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes. J Virol (1999) 1.44
Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions. J Virol (2003) 1.41
Role of Vif in stability of the human immunodeficiency virus type 1 core. J Virol (2000) 1.34
Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells. J Virol (2009) 1.26
Feline lentivirus evolution in cross-species infection reveals extensive G-to-A mutation and selection on key residues in the viral polymerase. J Virol (2006) 1.20
Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee. J Virol (2003) 1.20
Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors. Microbiol Mol Biol Rev (2009) 1.12
Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1. J Virol (2002) 1.03
High-throughput human immunodeficiency virus type 1 (HIV-1) full replication assay that includes HIV-1 Vif as an antiviral target. Antimicrob Agents Chemother (2005) 1.03
Human immunodeficiency virus and AIDS: insights from animal lentiviruses. J Virol (2000) 1.03
Cellular and viral specificities of human immunodeficiency virus type 1 vif protein. J Virol (2000) 1.02
Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC. J Virol (2012) 1.01
Productive replication of Vif-chimeric HIV-1 in feline cells. J Virol (2010) 0.99
The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells. Virology (2006) 0.92
Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells. J Virol (2007) 0.91
Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function. J Virol (2002) 0.91
Feline immunodeficiency virus Vif localizes to the nucleus. J Virol (2000) 0.90
HIV restriction in quiescent CD4⁺ T cells. Retrovirology (2013) 0.88
Quiescent T cells and HIV: an unresolved relationship. Immunol Res (2010) 0.87
ADAR1 is a novel multi targeted anti-HIV-1 cellular protein. Virology (2011) 0.86
Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass. Biochem J (2004) 0.86
Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif. J Virol (2004) 0.86
SIV replication in human cells. Front Microbiol (2012) 0.84
APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans. Mol Biol Int (2012) 0.84
Restriction of Retroviral Replication by Tetherin/BST-2. Mol Biol Int (2012) 0.80
HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors. Front Microbiol (2013) 0.80
Insights into the dual activity of SIVmac239 Vif against human and African green monkey APOBEC3G. PLoS One (2012) 0.80
The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation. Retrovirology (2015) 0.78
Systems-biology approaches to discover anti-viral effectors of the human innate immune response. Viruses (2011) 0.78
Controlling lentiviruses: single amino acid changes can determine specificity. Proc Natl Acad Sci U S A (2004) 0.76
Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol (1981) 13.11
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1989) 12.54
Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol Cell Biol (1985) 7.49
A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res (1995) 7.08
Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol (1994) 6.67
Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature (1988) 6.28
The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science (1987) 6.16
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol (1993) 6.11
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J Virol (1992) 5.85
Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science (1992) 5.25
Assembly and morphology of HIV: potential effect of structure on viral function. AIDS (1991) 4.73
Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol (1993) 4.20
Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J Virol (1994) 3.85
Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J Virol (1993) 3.75
A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell (1990) 3.70
Assembly of type C oncornaviruses: a model. Science (1978) 3.53
The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J Virol (1996) 3.22
Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. EMBO J (1994) 3.19
Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J Virol (1993) 3.12
Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J Virol (1993) 3.01
A quantitative bioassay for HIV-1 based on trans-activation. Science (1988) 2.99
Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J Virol (1995) 2.45
Conservation of amino-acid sequence motifs in lentivirus Vif proteins. Virus Genes (1992) 2.40
The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J Virol (1997) 2.39
Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J Virol (1995) 2.35
Role of Vif in human immunodeficiency virus type 1 reverse transcription. J Virol (1996) 2.35
Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J Virol (1996) 2.33
Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J Virol (1996) 2.30
The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J Virol (1995) 2.25
Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J Virol (1995) 2.19
Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res Hum Retroviruses (1994) 2.18
Cell-free transmission of Vif mutants of HIV-1. Virology (1992) 2.13
Role of vif during packing of the core of HIV-1. Virology (1994) 2.01
Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. J Virol (1996) 1.76
Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J Virol (1996) 1.69
Cross-species transmission and recombination of 'AIDS' viruses. Philos Trans R Soc Lond B Biol Sci (1995) 1.68
Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology. J Virol (1997) 1.60
Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J Virol (1992) 1.59
A distinct African lentivirus from Sykes' monkeys. J Virol (1993) 1.58
Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. J Acquir Immune Defic Syndr (1994) 1.58
Type D primate retroviruses: a review. Cancer Res (1978) 1.39
Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J Virol (1997) 1.38
Both virus and host components are important for the manifestation of a Nef- phenotype in HIV-1 and HIV-2. Virology (1995) 1.32
A full-length and replication-competent proviral clone of SIVAGM from tantalus monkeys. Virology (1997) 1.30
Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1. J Gen Virol (1997) 1.27
In vivo genetic variability of the HIV-1 vif gene. Virology (1994) 1.18
Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants. J Virol (1995) 1.11
Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology (1996) 1.06
Functional analysis of long terminal repeats derived from four strains of simian immunodeficiency virus SIVAGM in relation to other primate lentiviruses. Virology (1991) 0.94
A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med (2001) 16.32
Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol (2000) 8.62
Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed) (1981) 8.48
Isolation of mutants of an animal virus in bacteria. Science (1980) 6.81
Prostitution and risk of HIV: female prostitutes in London. BMJ (1993) 6.06
Revised sequence of the tetracycline-resistance gene of pBR322. Gene (1983) 5.42
Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill (2012) 4.96
Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol (2001) 4.90
The HIV-1 Rev protein. Annu Rev Microbiol (1998) 4.78
Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J Exp Med (1991) 4.56
Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci U S A (1997) 4.07
Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat Med (1998) 3.84
Epidemiology of the Hong Kong-68 variant of influenza A2 in Britain. Br Med J (1971) 3.74
Mutational analysis of simian virus 40 T antigen: isolation and characterization of mutants with deletions in the T-antigen gene. Mol Cell Biol (1983) 3.67
Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science (1993) 3.62
Inflammatory pseudotumors of the lung. Ann Thorac Surg (1999) 3.51
Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc Natl Acad Sci U S A (1989) 3.43
Functional organization of the simian virus 40 origin of DNA replication. Mol Cell Biol (1986) 3.40
The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev (1994) 3.34
Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein. Nature (1988) 3.31
HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science (1998) 3.28
Poliomyelitis surveillance in England and Wales, 1965-8. Public Health (1970) 3.25
The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J Virol (1996) 3.22
Facilities and diagnostic criteria in sexually transmitted disease clinics in England and Wales. Br J Vener Dis (1978) 3.21
Lobar torsion after pulmonary resection: presentation and outcome. J Thorac Cardiovasc Surg (2001) 3.16
Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. Genes Dev (1989) 3.09
Reverse transcriptase activity and Ty RNA are associated with virus-like particles in yeast. Nature (1986) 3.07
Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol (2000) 2.96
Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med (1991) 2.93
Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J Virol (1989) 2.89
STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med (1997) 2.86
Discrepancies in immunization records. Community Med (1980) 2.85
Attendance at a London casualty department. J R Coll Gen Pract (1977) 2.84
Primary structure of elongation factor Tu from Escherichia coli. Proc Natl Acad Sci U S A (1980) 2.72
Influenza B virus in seals. Science (2000) 2.70
Completeness of statutory notification for acute bacterial meningitis. Br Med J (1976) 2.58
The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J Virol (1997) 2.39
Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J Virol (1995) 2.35
HIV-1 infection requires a functional integrase NLS. Mol Cell (2001) 2.26
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol (2000) 2.25
The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes Dev (1992) 2.24
Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev action. Genes Dev (1990) 2.24
A new SIV co-receptor, STRL33. Nature (1997) 2.23
Influenza in Britain 1967-68. J Hyg (Lond) (1969) 2.18
Bronchobiliary fistula: principles of management. Ann Thorac Surg (2000) 2.15
A pilot study of sexual lifestyle in a random sample of the population of Great Britain. AIDS (1989) 2.13
Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med (1995) 2.05
Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol (1997) 2.05
Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol (2000) 2.04
Studies on the purification and properties of factor Tu from E. coli. Arch Biochem Biophys (1970) 2.02
The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions. J Virol (1989) 2.00
Novel roles for saccharomyces cerevisiae mitotic spindle motors. J Cell Biol (1999) 1.99
Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells. Mol Endocrinol (2001) 1.96
Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc Natl Acad Sci U S A (1992) 1.96
Characterization of the yeast mitochondrial locus necessary for tRNA biosynthesis: DNA sequence analysis and identification of a new transcript. Cell (1983) 1.93
The cytosensor microphysiometer: biological applications of silicon technology. Science (1992) 1.93
Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1. J Virol (1994) 1.92
Importin beta can mediate the nuclear import of an arginine-rich nuclear localization signal in the absence of importin alpha. Mol Cell Biol (1999) 1.91
A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. Nucleic Acids Res (1990) 1.90
Amphibian transcription factor IIIA proteins contain a sequence element functionally equivalent to the nuclear export signal of human immunodeficiency virus type 1 Rev. Proc Natl Acad Sci U S A (1996) 1.87
RNA editing by cytidine insertion in mitochondria of Physarum polycephalum. Nature (1991) 1.85
Early and long-term results of prosthetic chest wall reconstruction. J Thorac Cardiovasc Surg (1999) 1.83
Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual. J Virol (1991) 1.83
Local mutagenesis within deletion loops of DNA heteroduplexes. Proc Natl Acad Sci U S A (1982) 1.81
Mutational analysis of simian virus 40 T antigen: stimulation of cellular DNA synthesis and activation of rRNA genes by mutants with deletions in the T-antigen gene. Mol Cell Biol (1983) 1.81
Rotavirus serotypes 6 and 10 predominate in cattle. J Clin Microbiol (1990) 1.81
Secreted placental alkaline phosphatase as a eukaryotic reporter gene. Methods Enzymol (1992) 1.80
Whooping cough and whooping cough vaccine: the risks and benefits debate. Epidemiol Rev (1982) 1.79
Localization and surgical treatment of occult insulinomas. Ann Surg (1990) 1.76
Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. J Virol (1996) 1.76
Total recovery studies of nonabsorbable indicators in the rat small intestine. Gastroenterology (1970) 1.76
A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol (1996) 1.74
Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions. AIDS Res Hum Retroviruses (1996) 1.74
Changing virus-host interactions in the course of HIV-1 infection. Immunol Rev (1994) 1.73
Behavioral intervention to improve calorie intake of children with cystic fibrosis: treatment versus wait list control. J Pediatr Gastroenterol Nutr (1996) 1.70
Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J Virol (1998) 1.70
Trace chemistries of fire: a source of chlorinated dioxins. Science (1980) 1.69
The HIV-1 Rev protein: prototype of a novel class of eukaryotic post-transcriptional regulators. Trends Biochem Sci (1991) 1.67
Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology (1992) 1.66
Nuclear import of human immunodeficiency virus type-1 preintegration complexes. Adv Virus Res (1999) 1.63
Phosphorylation of the rev gene product of human immunodeficiency virus type 1. J Virol (1988) 1.61
Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology. J Virol (1997) 1.60
Insulinomas: localization with selective intraarterial injection of calcium. Radiology (1991) 1.58
Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism. Ann Surg (1992) 1.57
Gastrinomas: localization by means of selective intraarterial injection of secretin. Radiology (1990) 1.56
Analysis of the junctions between human immunodeficiency virus type 1 proviral DNA and human DNA. J Virol (1990) 1.54
Photometric detection of ATP release from human erythrocytes exposed to ultrasonically activated gas-filled pores. Ultrasound Med Biol (1980) 1.53
Mutational analysis of the human immunodeficiency virus type 1 Vif protein. J Virol (1999) 1.52
Influenza virus: a master of metamorphosis. J Infect (2000) 1.50
Reye's syndrome in children under three years old. Arch Dis Child (1982) 1.50
Differential regulation of CXCR4 and CCR5 endocytosis. J Cell Sci (1998) 1.49